TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Unimedic Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
255,981
|
210,828
|
180,509 |
Financial expenses |
2,551
|
1,424
|
785 |
Earnings before taxes |
49,144
|
45,134
|
21,939 |
EBITDA |
55,633
|
51,230
|
27,291 |
Total assets |
133,944
|
132,839
|
99,296 |
Current assets |
123,855
|
118,148
|
82,133 |
Current liabilities |
38,625
|
56,813
|
44,226 |
Equity capital |
50,837
|
24,638
|
14,701 |
- share capital |
134
![]() |
134
|
145 |
Employees (average) |
27
![]() |
27
|
25 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
38.0%
|
18.5%
|
14.8% |
Turnover per employee |
9,481
|
7,808
|
7,220 |
Profit as a percentage of turnover |
19.2%
|
21.4%
|
12.2% |
Return on assets (ROA) |
38.6%
|
35.0%
|
22.9% |
Current ratio |
320.7%
|
208.0%
|
185.7% |
Return on equity (ROE) |
96.7%
|
183.2%
|
149.2% |
Change turnover |
44,067
|
44,941
|
3,929 |
Change turnover % |
21%
|
27%
|
2% |
Chg. No. of employees |
0
|
2
![]() |
2 |
Chg. No. of employees % |
0%
|
8%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.